相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small Molecules with Big Impacts on Cardiovascular Diseases
Fatemeh Mirzadeh Azad et al.
BIOCHEMICAL GENETICS (2020)
Worldwide Prevalence of Familial Hypercholesterolemia Meta-Analyses of 11 Million Subjects
Sabina O. Beheshti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The complex molecular genetics of familial hypercholesterolaemia
Amanda J. Berberich et al.
NATURE REVIEWS CARDIOLOGY (2019)
Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development
Aner Mesic et al.
BMC CANCER (2019)
The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients
Denise S. Pinheiro et al.
PLOS ONE (2019)
The Elusive Inhibitory Function of the Acidic N-Terminal Segment of the Prodomain of PCSK9: The Plot Thickens
Nabil G. Seidah
JOURNAL OF MOLECULAR BIOLOGY (2019)
Genetic Architecture of Familial Hypercholesterolaemia
Mahtab Sharifi et al.
CURRENT CARDIOLOGY REPORTS (2017)
Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
Parisa Naeli et al.
FRONTIERS IN GENETICS (2017)
The study of familial hypercholesterolemia in Italy: A narrative review
Stefano Bertolini et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies
Petra El Khoury et al.
CURRENT ATHEROSCLEROSIS REPORTS (2017)
Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death
Henriette Walaas Krogh et al.
EUROPEAN HEART JOURNAL (2016)
Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?
Alpo Vuorio et al.
EUROPEAN HEART JOURNAL (2016)
Genetics of Familial Hypercholesterolemia
Ariel Brautbar et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2015)
L-CARNITINE SUPPLEMENTATION DECREASES LIPID PEROXIDATION AND IMPROVES CARDIOPULMONARY FUNCTION IN BROILER CHICKENS REARED AT HIGH ALTITUDE
Fariborz Khajali et al.
ACTA VETERINARIA HUNGARICA (2014)
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials
Evan A. Stein et al.
EUROPEAN HEART JOURNAL (2014)
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel et al.
EUROPEAN HEART JOURNAL (2014)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
Loss- and Gain-of-function PCSK9 Variants CLEAVAGE SPECIFICITY, DOMINANT NEGATIVE EFFECTS, AND LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) DEGRADATION
Suzanne Benjannet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Molecular Characterization of Iranian Patients with Possible Familial Hypercholesterolemia
E. Farrokhi et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2011)
Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia
Radan Goldmann et al.
BMC MEDICAL GENETICS (2010)
An Iranian-Armenian LDLR frameshift mutation causing familial hypercholesterolemia
H. K. Jensen et al.
CLINICAL GENETICS (2010)
Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia
E. Merino-Ibarra et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing
SE Humphries et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
LOVD: Easy creation of a locus-specific sequence variation database using an LSDB-in-a-Box approach
IFAC Fokkema et al.
HUMAN MUTATION (2005)
The UMD-LDLR database: Additions to the software and 490 new entries to the database
L Villeger et al.
HUMAN MUTATION (2002)
Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair
H Jeon et al.
NATURE STRUCTURAL BIOLOGY (2001)
A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom
KE Heath et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)
Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia
R Thiart et al.
JOURNAL OF MEDICAL GENETICS (2000)
分享论文
